ConductScience.org, home

Library / Trial comparisons

Arm I: Attention Bias Modification (ABM) Training vs Arm II: Sham Training: deaths from any cause

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 1000.03wilsonClinicalTrials.gov
Risk in group 2000.0305wilsonClinicalTrials.gov
Risk difference, group 1 minus group 20-0.03050.03newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 2loga group has no participants with the outcomeClinicalTrials.gov
Odds ratio, group 1 over group 2loga cell of the two-by-two table is zeroClinicalTrials.gov
Number needed to harmfrom the risk difference intervalthe two groups' risks are equalClinicalTrials.gov

Groups 2

Group 2 names the comparator: sham.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1Arm I: Attention Bias Modification (ABM) TrainingPatients receive ABM training over 30 minutes through a smartphone on days 1-14. Patients then receive nicotine patches for up to 8 weeks.0124EG000ClinicalTrials.gov
Group 2Arm II: Sham TrainingPatients undergo sham training on days 1-14. Patients then receive nicotine patches for up to 8 weeks.0122EG001ClinicalTrials.gov

Harm 2

FieldValueSource
What it countsTotal, all-cause mortalityClinicalTrials.gov
Time frame12 weeksClinicalTrials.gov

Trial 8

FieldValueSource
TitleSmartphone-Delivered Attentional Bias Modification Training in Helping Patients Quit SmokingClinicalTrials.gov
NCT numberNCT02224391ClinicalTrials.gov
PhasesNAClinicalTrials.gov
ConditionsCurrent Every Day SmokerClinicalTrials.gov
InterventionsComputer-Assisted Smoking Cessation Intervention, Laboratory Biomarker Analysis, Nicotine Patch, Questionnaire Administration, Sham InterventionClinicalTrials.gov
Lead sponsorM.D. Anderson Cancer CenterClinicalTrials.gov
Results first posted2022-09-28ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT02224391?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.